© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Latest Conference Articles
Does Skin Tone Affect Efficacy of Therapy for Atopic Dermatitis? Probably Not
March 24th 2025
AAD 2025: Raj Chovatiya, MD, PhD, MSCI, well-known physician scientist, says underrepresentation in clinical trials of those with skin of color precludes an evidence-based answer.
The Exposome is Everything in Atopic Dermatitis: An Expert Perspective on AD Pathophysiology
March 21st 2025
Raj Chovatiya, MD, PhD, MSCI, discusses the complex and widely variable influences that affect the manifestations and burden of atopic dermatitis across populations.
Melanin Isn't Everything: Skin Physiology Does Not Conform to Socially Defined Variables, Explains Raj Chovatiya, MD, PhD, MSCI
March 20th 2025
AAD 2025: Chovatiya discusses whether melanin concentration plays a role in skin physiology and cautioned against typing with factors that are not true biologic constructs.
Dupilumab Found Beneficial in COPD with Type 2 Inflammation: Daily Dose
March 20th 2025
Your daily dose of the clinical news you may have missed.
Roflumilast Cream Shows Strong Tolerability in Patients with AD Failing Other Topicals: Daily Dose
March 19th 2025
Your daily dose of the clinical news you may have missed.
What We Mean When We Say "Skin of Color" in Dermatology: A Closer Look with Raj Chovatiya, MD, PhD, MSCI
March 19th 2025
Chovatiya, expert clinical dermatologist and researcher, points out that the term "skin of color" comprises a heterogenous set of topics, in an interview at AAD 2025.
Managing Atopic Dermatitis in Special Populations: Expert Insights for Primary Care
March 18th 2025
In an interview at AAD 2025, Katrina Abuabara, MD, stressed the importance of collaboration between primary care physicians and dermatologists.
Antihistamines Are a Poor Option to Treat Eczema in Older Adults: Clinical Pearl
March 18th 2025
Antihistamines for itch caused by disorders like atopic dermatitis pose more problems, like sedation and fall risk, than they provide relief, according to Daniel Butler, MD.
Emergence of Trichophyton Indotineae: A Call for Culture-Driven Antifungal Therapy
March 17th 2025
Elizabeth Swanson, MD, shares how the rise of T.indotineae, a terbinafine-resistant fungal species, has shifted her treatment approach.
Epinephrine Nasal Spray Shows Rapid Symptom Relief in Children: Daily Dose
March 17th 2025
Your daily dose of the clinical news you may have missed.